• English
  • Korean
  • Chinese
市場調査レポート - 239911

米国の整形外科用生体材料市場

U.S Orthopedic Biomaterials Market

発行 iData Research Inc.
出版日 ページ情報 英文 273 Pages
価格
米国の整形外科用生体材料市場 U.S Orthopedic Biomaterials Market
出版日: 2013年08月02日 ページ情報: 英文 273 Pages
概要

米国の整形外科用生体材料の市場規模は約34億米ドルに達しました。歴史の浅い分野(肝細胞、濃縮システムなど)では特に急速な成長が生じるものと思われます。かつて急速に成長していた部門も、成熟期には入りますが、製品の進化が引き続き進行していくものと思われます。

当レポートでは、米国の整形外科用生体材料(バイオマテリアル)市場について調査分析し、装置(用具)タイプ別に、市場収益の予測額(今後7年間分)や、販売数、平均販売価格、市場促進要因・阻害要因などを検証し、市場シェアや製品ポートフォリオなどの競合分析も含めて、概略以下の構成でお届けいたします。

第1章 エグゼクティブサマリー

第2章 調査手法

第3章 米国の整形外科用生体材料市場の概要

  • イントロダクション
  • 市場概要
  • 市場動向の分析
  • 市場促進要因と阻害要因
  • 競合分析
  • 市場集中度
  • 企業合併・買収(M&A)

第4章 骨移植片代替物市場

  • イントロダクション
  • 市場セグメンテーション
  • 処置
  • 処置当たり数量
  • 市場概要
  • 市場分析と予測
  • 市場促進要因と阻害要因
  • 競合分析

第5章 増殖因子市場

  • イントロダクション
  • 市場概要
  • 市場分析と予測
  • 市場促進要因と阻害要因
  • 競合分析

第6章 整形外科用幹細胞市場

  • イントロダクション
  • 市場概要
  • 市場分析と予測
  • 市場促進要因と阻害要因
  • 競合分析

第7章 整形外科用細胞治療市場

  • イントロダクション
  • 市場概要
  • 市場分析と予測
  • 市場促進要因と阻害要因
  • 競合分析

第8章 ヒアルロン酸関節内補充治療市場

  • イントロダクション
  • 市場概要
  • 市場分析と予測
  • 市場促進要因と阻害要因
  • 競合分析

第9章 腱移植市場

  • イントロダクション
  • 市場概要
  • 市場予測と分析
  • 市場促進要因と阻害要因
  • 競合分析

第10章 軟骨修復市場

  • イントロダクション
  • 市場概要
  • 市場予測と分析
  • 市場促進要因と阻害要因
  • 競合分析

第11章 脊椎加工骨同種移植片市場

  • イントロダクション
  • 市場概要
  • 市場予測と分析
  • 市場促進要因と阻害要因
  • 競合分析

略語

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

The orthopedic biomaterials market has undergone a shift away from certain devices and towards new areas and medical devices. There is still tremendous potential for growth, especially in the younger market segments such as stem cells and concentration systems.

Conversely, some products that previously experienced rapid market growth have now entered maturity, but even these markets are sustained by continued product evolution.

Scope:

This report pertains to a forecast period of 10 years (2009 - 2019) for the U.S.

Report Contents:

  • Competitor Analysis
  • Identified Strategic Opportunities
  • Market Overview by Segment & Country
  • Trend Analysis by Segment & Country
  • Market Drivers & Limiters
  • Mergers & Acquisitions
  • Customer Feedback and Market Monitoring

Main Segments Included:

  • Orthopedic Bone Graft Substitute
  • Orthopedic Growth Factor
  • Orthopedic Stem Cell
  • Orthopedic Cell Therapy
  • Orthopedic Hyaluronic Acid Viscosupplementation
  • Orthopedic Tendon Graft
  • Orthopedic Cartilage Repair
  • Spinal Machined Bone Allograft

Sub-Segments Included:

  • Autograft
  • Standard Allograft
  • Demineralized Bone Matrix
  • Synthetic Bone Graft
  • Xenograft
  • BMP-2
  • BMP-7
  • Human Embryonic Stem Cells
  • Mesengchymal Stem Cells
  • Lumbar Spine Stem Cells
  • Cervical Spine Stem Cells
  • Platelet-Rich Plasma
  • Orthopedic Concentrated Bone Marrow Aspirate
  • Single-Injection
  • Three-Injection Cycle
  • Three/Five-Injection Cycle
  • BTB Graft
  • Soft Tissue Grafts
  • Ligament and Tendon Synthetic Graft
  • Osteochondral Allograft
  • Autologous Chondrocyte Implantation
  • Meniscal Allograft Tansplantation
  • ALIF Machined Bone Allograft
  • PLIF Machined Bone Allograft
  • TLIF Machined Bone Allograft
  • CIF Machined Bone Allograft

Companies Included:

  • Sanofi-Aventis/Genzyme
  • Bioventus
  • DePuy Synthes
  • Medtronic
  • Musculoskeletal Transplant Foundation
  • Stryker
  • RTI Biologics
  • NuVasive
  • Orthofix
  • LifeNet Health
  • AlloSource
  • Integra LifeSciences
  • Anika Therapeutics
  • Biomet
  • Ferring Pharmaceuticals
  • Exactech
  • Baxter
  • Harvest Technologies
  • Cytomedix
  • Wright Medical
  • Community Tissue Services
  • Olympus Biotech
  • Fidia
  • Arteriocyte
  • Alphatec Spine
  • Joint Restoration Foundation
  • University of Miami Tissue Bank
  • Celling Biosciences
  • Zimmer

Reasons To Buy:

This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our "ground up" approach, which includes primary and secondary research methods.

Table of Contents

TABLE OF CONTENTS I

LIST OF FIGURES IX

LIST OF CHARTS XV

EXECUTIVE SUMMARY 1

  • 1.1 ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 1
  • 1.2 ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET 2
  • 1.3 ORTHOPEDIC GROWTH FACTOR MARKET 3
  • 1.4 ORTHOPEDIC STEM CELL MARKET 4
  • 1.5 ORTHOPEDIC CELL THERAPY MARKET 5
  • 1.6 ORTHOPEDIC HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 6
  • 1.7 ORTHOPEDIC TENDON GRAFT MARKET 7
  • 1.8 ORTHOPEDIC CARTILAGE REPAIR MARKET 8
  • 1.9 COMPETITIVE ANALYSIS 9

RESEARCH METHODOLOGY 11

  • 2.1 RESEARCH SCOPE 11
  • 2.2 IDATA'S 9-STEP METHODOLOGY 11
    • Step 1: Project Initiation & Team Selection 12
    • Step 2: Prepare Data Systems and Perform Secondary Research 13
    • Step 3: Preparation for Interviews & Questionnaire Design 14
    • Step 4: Performing Primary Research 14
    • Step 5: Research Analysis: Establishing Baseline Estimates 16
    • Step 6: Market Forecast and Analysis 17
    • Step 7: Identify Strategic Opportunities 19
    • Step 8: Final Review and Market Release 20
    • Step 9: Customer Feedback and Market Monitoring 20

ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 21

  • 3.1 INTRODUCTION 21
    • 3.1.1 Bone Graft Substitutes 22
    • 3.1.2 Growth Factors 22
    • 3.1.3 Orthopedic Stem Cell Therapy 23
    • 3.1.4 Cell Therapies 23
    • 3.1.5 Hyaluronic Acid Viscosupplementation 24
    • 3.1.6 Tendon Grafts 24
    • 3.1.7 Cartilage Repair 24
  • 3.2 MARKET OVERVIEW 25
  • 3.3 TREND ANALYSIS 30
  • 3.4 MARKET DRIVERS AND LIMITERS 33
    • 3.4.1 Market Drivers 33
    • 3.4.2 Market Limiters 33
  • 3.5 COMPETITIVE ANALYSIS 36
    • 3.5.1 Leading Competitors 36
  • 3.6 MARKET CONCENTRATION 42
  • 3.7 MERGERS AND ACQUISITIONS 44

ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET 49

  • 4.1 INTRODUCTION 49
  • 4.2 MARKET SEGMENTATION 50
    • 4.2.1 By Indication 50
      • 4.2.1.1 Spine 50
      • 4.2.1.2 Thoracolumbar Spine 50
      • 4.2.1.3 Cervical Spine 50
      • 4.2.1.4 Trauma 51
      • 4.2.1.5 Extremities 51
    • 4.2.2 By Material 51
      • 4.2.2.1 Autograft 51
      • 4.2.2.2 Standard Allograft 51
      • 4.2.2.3 Demineralized Bone Matrix 51
      • 4.2.2.4 Synthetic 52
      • 4.2.2.5 Xenograft 52
  • 4.3 PROCEDURES 53
    • 4.3.1 Bone Graft Substitute Procedures 53
  • 4.4 UNITS PER PROCEDURE 54
  • 4.5 MARKET OVERVIEW 56
    • 4.5.1 Bone Graft Substitute Market by Material 58
    • 4.5.2 Bone Graft Substitute Market by Indication 61
  • 4.6 MARKET ANALYSIS & FORECAST 64
    • 4.6.1 Bone Graft Substitute Market by Material 64
      • 4.6.1.1 Total Allograft Bone Graft Substitute Market 64
      • 4.6.1.2 Total Demineralized Bone Matrix (DBM) Bone Graft Substitute Market 79
      • 4.6.1.3 Total Synthetic Bone Graft Substitute Market 96
    • 4.6.2 Bone Graft Substitute Market by Indication 111
      • 4.6.2.1 Spine Bone Graft Substitute Market 111
      • 4.6.2.2 Cervical Spine Bone Graft Substitute Market 113
      • 4.6.2.3 Thoracolumbar Spine Bone Graft Substitute Market 115
      • 4.6.2.4 Trauma Bone Graft Substitute Market 117
      • 4.6.2.5 Non-union Trauma Fracture Bone Graft Substitute Market 119
      • 4.6.2.6 Fresh Fracture Trauma Bone Graft Substitute Market 120
      • 4.6.2.7 Large Joint Reconstruction Bone Graft Substitute Market 121
      • 4.6.2.8 Hip Large Joint Reconstruction Bone Graft Substitute Market 123
      • 4.6.2.9 Knee Large Joint Reconstruction Bone Graft Substitute Market 124
      • 4.6.2.10 Foot Reconstruction Bone Graft Substitute Market 125
      • 4.6.2.11 Craniomaxillofacial Bone Graft Substitute Market 127
      • 4.6.2.12 Oncology Bone Graft Substitute Market 129
  • 4.7 MARKET DRIVERS AND LIMITERS 131
    • 4.7.1 Market Drivers 131
      • 4.7.1.1 Allograft Bone Graft Substitute Market 131
      • 4.7.1.2 Demineralized Bone Matrix (DBM) Bone Graft Substitute Market 131
      • 4.7.1.3 Synthetic Bone Graft Substitute Market 132
    • 4.7.2 Market Limiters 134
      • 4.7.2.1 Allograft Bone Graft Substitute Market 134
      • 4.7.2.2 Demineralized Bone Matrix (DBM) Bone Graft Substitute Market 134
      • 4.7.2.3 Synthetic Bone Graft Substitute Market 135
  • 4.8 COMPETITIVE ANALYSIS 136
    • 4.8.1 Allograft Bone Graft Substitute Market 136
    • 4.8.2 Demineralized Bone Matrix (DBM) Bone Graft Substitute Market 140
    • 4.8.3 Synthetic Bone Graft Substitute Market 143
    • 4.8.4 Total Bone Graft Substitute Market 147

ORTHOPEDIC GROWTH FACTOR MARKET 149

  • 5.1 INTRODUCTION 149
  • 5.2 MARKET OVERVIEW 149
    • 5.2.1 BMP-2 (Medtronic) 150
    • 5.2.2 BMP-7 (Olympus Biomaterials) 150
    • 5.2.3 Reimbursement 151
    • 5.2.4 Future Indications 151
  • 5.3 MARKET ANALYSIS & FORECAST 152
  • 5.4 MARKET DRIVERS AND LIMITERS 154
    • 5.4.1 Market Drivers 154
    • 5.4.2 Market Limiters 154
  • 5.5 COMPETITIVE ANALYSIS 157

ORTHOPEDIC STEM CELL MARKET 159

  • 6.1 INTRODUCTION 159
  • 6.2 MARKET OVERVIEW 159
    • 6.2.1 Lineage 159
      • 6.2.1.1 Human Embryonic Stem Cells (hESC) 159
      • 6.2.1.2 Mesenchymal Stem Cells (MSC) 160
    • 6.2.2 Legislation 160
    • 6.2.3 Other Therapeutic Applications 160
  • 6.3 MARKET ANALYSIS & FORECAST 161
    • 6.3.1.1 Lumbar Spine Stem Cell Market 165
    • 6.3.1.2 Cervical Spine Stem Cell Market 167
  • 6.4 DRIVERS AND LIMITERS 169
    • 6.4.1 Market Drivers 169
    • 6.4.2 Market Limiters 169
  • 6.5 COMPETITIVE ANALYSIS 171

ORTHOPEDIC CELL THERAPY MARKET 175

  • 7.1 INTRODUCTION 175
    • 7.1.1 Platelet-Rich Plasma 176
    • 7.1.2 Concentrated Bone Marrow Aspirate 177
  • 7.2 MARKET OVERVIEW 178
  • 7.3 MARKET ANALYSIS & FORECAST 182
    • 7.3.1 Platelet-Rich Plasma Market 182
      • 7.3.1.1 Spinal Platelet-Rich Plasma Market 187
      • 7.3.1.2 Soft Tissue Reconstruction Platelet-Rich Plasma Market 188
      • 7.3.1.3 Joint Reconstruction Platelet-Rich Plasma Market 189
      • 7.3.1.4 Cardiac Surgery Platelet-Rich Plasma Market 190
      • 7.3.1.5 Other Platelet-Rich Plasma Markets 191
    • 7.3.2 Orthopedic Concentrated Bone Marrow Aspirate Market 192
      • 7.3.2.1 Spine Concentrated Bone Marrow Aspirate Market 197
      • 7.3.2.2 Trauma Concentrated Bone Marrow Aspirate Market 198
      • 7.3.2.3 Joint Reconstruction Concentrated Bone Marrow Aspirate Market 199
      • 7.3.2.4 Other Concentrated Bone Marrow Aspirate Market 200
  • 7.4 MARKET DRIVERS AND LIMITERS 201
    • 7.4.1 Market Drivers 201
    • 7.4.2 Market Limiters 202
  • 7.5 COMPETITIVE ANALYSIS 204

ORTHOPEDIC HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 207

  • 8.1 INTRODUCTION 207
    • 8.1.1 Benefits of Viscosupplementation 208
    • 8.1.2 Synovial Fluid 208
    • 8.1.3 Product Types 209
      • 8.1.3.1 Single-Injection Products 209
      • 8.1.3.2 Three-Injection Cycle Products 209
      • 8.1.3.3 Three/Five-Injection Cycle Products 209
    • 8.1.4 Reimbursement 209
  • 8.2 MARKET OVERVIEW 210
  • 8.3 MARKET ANALYSIS & FORECAST 214
    • 8.3.1 Single-Injection Hyaluronic Acid Viscosupplementation Market 214
    • 8.3.2 Three-Injection Hyaluronic Acid Viscosupplementation Market 216
    • 8.3.3 Five-Injection Hyaluronic Acid Viscosupplementation Market 218
  • 8.4 MARKET DRIVERS AND LIMITERS 220
    • 8.4.1 Market Drivers 220
    • 8.4.2 Market Limiters 221
  • 8.5 COMPETITIVE ANALYSIS 223

ORTHOPEDIC TENDON GRAFT MARKET 227

  • 9.1 INTRODUCTION 227
  • 9.2 MARKET OVERVIEW 228
    • 9.2.1 BTB 228
    • 9.2.2 Soft Tissue Grafts 228
    • 9.2.3 Allografted Tendons 228
    • 9.2.4 Ligament and Tendon Synthetic Grafts 229
  • 9.3 MARKET ANALYSIS & FORECAST 230
    • 9.3.1 ACL/PCL Reconstruction Procedures 230
    • 9.3.2 ACL/PCL Allograft Tendon Market 232
  • 9.4 DRIVERS AND LIMITERS 234
    • 9.4.1 Market Drivers 234
    • 9.4.2 Market Limiters 235
  • 9.5 COMPETITIVE ANALYSIS 236

ORTHOPEDIC CARTILAGE REPAIR MARKET 239

  • 10.1 INTRODUCTION 239
    • 10.1.1 Anatomy 239
    • 10.1.2 Methods for Cartilage Repair 240
      • 10.1.2.1 Osteochondral Allograft Transfer 240
      • 10.1.2.2 Autologous Chondrocyte Implantation (ACI) 240
      • 10.1.2.3 Meniscal Allograft Transplantation 240
    • 10.2 MARKET OVERVIEW 241
  • 10.3 MARKET ANALYSIS AND FORECAST 245
    • 10.3.1 Osteochondral Cartilage Allograft Market 246
    • 10.3.2 Meniscal Allograft Market 247
    • 10.3.3 Autologous Chondrocyte Implantation Market 248
  • 10.4 MARKET DRIVERS AND LIMITERS 249
    • 10.4.1 Market Drivers 249
    • 10.4.2 Market Limiters 249
  • 10.5 COMPETITIVE ANALYSIS 251

SPINAL MACHINED BONE ALLOGRAFT MARKET 255

  • 11.1 INTRODUCTION 255
    • 11.1.1 Machined Bone 257
  • 11.2 MARKET OVERVIEW 258
  • 11.3 MARKET ANALYSIS & FORECAST 261
    • 11.3.1 Spinal Machined Bone Allograft Market by Segment 261
      • 11.3.1.1 ALIF Machined Bone Allograft Market 262
      • 11.3.1.2 PLIF Machined Bone Allograft Market 263
      • 11.3.1.3 TLIF Machined Bone Allograft Market 264
      • 11.3.1.4 CIF Machined Bone Allograft Market 265
  • 11.4 MARKET DRIVERS AND LIMITERS 266
    • 11.4.1 Market Drivers 266
    • 11.4.2 Market Limiters 267
  • 11.5 COMPETITIVE ANALYSIS 270

ABBREVIATIONS 273

Back to Top